Clinical Trials Directory

Trials / Completed

CompletedNCT01067599

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2

Novel Determinants and Measures of Smokeless Tobacco Use: Study 2 Effects of Switching Levels of Nicotine and TSNA in Products on Smokeless Tobacco Use

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
278 (actual)
Sponsor
University of Minnesota · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The research project will determine the level of nicotine in ST products that will lead to the greatest reduction in toxicant exposure

Detailed description

This is a randomized, multi-site trial determining the effects of switching smokeless tobacco (ST) users to lower toxicant ST products which vary in nicotine levels on biomarkers of exposure and patterns of use. ST users will undergo a two week baseline assessment period and then randomly assigned to one of three oral tobacco products (lower NNK plus NNN product with three different levels of nicotine) for a period of 8-weeks. Follow-up will occur at 9 and 20 weeks.

Conditions

Interventions

TypeNameDescription
OTHERLow nicotineComparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.
OTHERMedium nicotineComparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.
OTHERHigh nicotineComparison of different dosages of nicotine effect on tobacco use patterns, subjective response and biomarker levels.

Timeline

Start date
2012-03-01
Primary completion
2015-08-01
Completion
2016-10-01
First posted
2010-02-11
Last updated
2018-02-26

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01067599. Inclusion in this directory is not an endorsement.